Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024)
Bionano Genomics (BNGO) posted Other Operating Expenses of $138000.0 for Q4 2024, down 99.35% sequentially from $21.3 million in Q3 2024, and down 81.38% YoY from $741000.0 in Q1 2024.
Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024) Analysis & Trends
Bionano Genomics has reported Other Operating Expenses for 5 years, with the latest figure at $138000.0 in Q4 2024.
- Quarterly Other Operating Expenses fell 81.38% year-over-year to $138000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $138000.0 (down 99.51% YoY) and the FY2024 annual result came in at $27.7 million, down 64.49% from the prior year.
- Other Operating Expenses retreated to $138000.0 in Q4 2024 per BNGO's latest filing, from $21.3 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $77.3 million in Q3 2023 and troughed at $138000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 21.27 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 741,000.00 |
| Sep 30, 2023 | 77.28 Mn |
| Dec 31, 2019 | -403.00 |
| Dec 31, 2018 | 1.00 |
| Dec 31, 2017 | 604,511.00 |